Why MedReleaf Corp. Is Rallying Over 2%

MedReleaf Corp. (TSX:LEAF) is up over 2% following its Q3 2018 earnings release. What should you do now?

| More on:

MedReleaf Corp. (TSX:LEAF), North America’s first and only ICH-GMP and ISO 9001 certified cannabis producer, released its fiscal 2018 third-quarter earnings results this morning, and its stock has responded by rising over 2% in early trading. Let’s break down the quarterly results to determine if we should be long-term buyers today.

Extract growth leads to record sales and volume

Here’s a quick breakdown of 12 of the most notable statistics from MedReleaf’s three-month period ended December 31, 2017, compared with the same period in 2016:

Metric Q3 2018 Q3 2017 Change
Dried cannabis sales $8.57 million $9.83 million (12.8%)
Extracts sales $2.35 million $296,000 693.6%
Other sales $428,000 $299,000 43.1%
Total sales $11.35 million $10.43 million 8.9%
Gross profit $9.99 million $9.71 million 2.8%
Adjusted product contribution margin $7.33 million $8.59 million (14.7%)
Adjusted EBITDA (loss) ($233,000) $4.09 million (>100%)
Net income (loss) ($5.00 million) $1.74 million (>100%)
Net income (loss) per diluted share ($0.05) $0.02 (>100%)
Total grams sold 1,263,490 993,259 27.2%
Total average selling price per gram $8.98 $10.50 (14.5%)
Cash cost per gram produced $1.83 $1.55 18.1%

Notable commentary

In the press release, Neil Closner, the CEO of MedReleaf, summed up the quarter when he made the following statement:

“In the third quarter, we set new records for total sales and grams sold demonstrating the strength of our underlying business while we continue to make investments in preparation for the recreational market and for international expansion … We also launched our first adult recreational-use brand, San Rafael ’71, which is getting good reception from the various provincial purchase authorities. With a strong balance sheet bolstered by $192.5 million in equity capital raised since last December, we have a clear opportunity to establish MedReleaf as a global leader in the cannabis industry.”

What should you do now?

I think it was a solid quarter overall for MedReleaf, despite the negative earnings, highlighted by record sales and volume as a result of triple-digit sales growth of extract-based products. I also think its CEO is absolutely right when he said that the company has the opportunity to establish itself as “a global leader in the cannabis industry,” especially after the recent launch of its San Rafael ’71 brand, because it now has the potential to benefit from the explosive growth of both medical and recreational cannabis in the years ahead, as long as it executes its strategy.

With all of the information provided above in mind, I think investors seeking exposure to the cannabis industry should consider MedReleaf to be one of the best long-term investment options in the market today, but I must add that I prefer Canopy Growth Corp. (TSX:WEED) at current levels.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joseph Solitro has no position in any stocks mentioned.

More on Investing

Plane on runway, aircraft
Stocks for Beginners

Up 53% From its 52-Week Low, Is Cargojet Stock Still a Buy?

Cargojet (TSX:CJT) stock is up a whopping 53%, nearing closer to 52-week highs from 52-week lows, so what's next for…

Read more »

Question marks in a pile
Bank Stocks

Should You Buy Canadian Western Bank for its 4.8% Dividend Yield?

Down 35% from all-time highs, Canadian Western Bank offers a tasty dividend yield of 4.8%. Is the TSX bank stock…

Read more »

Gold bars
Metals and Mining Stocks

Why Alamos Gold Jumped 7% on Wednesday

Alamos (TSX:AGI) stock and Argonaut Gold (TSX:AR) surged after the companies announced a friendly acquisition for $325 million.

Read more »

tsx today
Stock Market

TSX Today: Why Record-Breaking Rally Could Extend on Thursday, March 28

The main TSX index closed above the 22,000 level for the first time yesterday and remains on track to post…

Read more »

Nuclear power station cooling tower
Metals and Mining Stocks

If You’d Invested $1,000 in Cameco Stock 5 Years Ago, This Is How Much You’d Have Now

Cameco (TSX:CCO) stock still looks undervalued, despite a 258% rally. Can the uranium miner deliver more capital gains to shareholders?

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Dividend Stocks

TFSA Magic: Earn Enormous Passive Income That the CRA Can’t Touch

If you're seeking out passive income, with zero taxes involved, then get on board with a TFSA and this portfolio…

Read more »

Man with no money. Businessman holding empty wallet
Dividend Stocks

2 Stocks Under $50 New Investors Can Confidently Buy

There are some great stocks under $50 that every investor needs to know about. Here’s a look at two great…

Read more »

potted green plant grows up in arrow shape
Stocks for Beginners

3 Growth Stocks I’m Buying in April

These three growth stocks are up in the last year, and that is likely to continue on as we keep…

Read more »